Derek J. Maetzold's most recent trade in Castle Biosciences Inc was a trade of 1,357 Common Stock done at an average price of $22.9 . Disclosure was reported to the exchange on July 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.92 per share. | 14 Jul 2026 | 1,357 | 39,353 (0%) | 0% | 22.9 | 31,102 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.92 per share. | 14 Jul 2026 | 1,153 | 33,449 (0%) | 0% | 22.9 | 26,427 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 14 Jul 2026 | 550 | 22,029 (0%) | 0% | 2.4 | 1,315 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.92 per share. | 14 Jul 2026 | 550 | 21,479 (0%) | 0% | 22.9 | 12,606 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2026 | 550 | 85,117 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.92 per share. | 14 Jul 2026 | 278 | 12,090 (0%) | 0% | 22.9 | 6,372 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.92 per share. | 14 Jul 2026 | 278 | 12,090 (0%) | 0% | 22.9 | 6,372 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.92 per share. | 14 Jul 2026 | 278 | 12,090 (0%) | 0% | 22.9 | 6,372 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.92 per share. | 14 Jul 2026 | 278 | 12,090 (0%) | 0% | 22.9 | 6,372 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 01 Jul 2026 | 6,214 | 21,479 (0%) | 0% | 24.3 | 150,938 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 01 Jul 2026 | 6,214 | 27,693 (0%) | 0% | 2.4 | 14,851 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 6,214 | 85,667 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 01 Jul 2026 | 1,357 | 40,710 (0%) | 0% | 24.3 | 32,962 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 01 Jul 2026 | 1,153 | 34,602 (0%) | 0% | 24.3 | 28,006 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 01 Jul 2026 | 278 | 12,368 (0%) | 0% | 24.3 | 6,753 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 01 Jul 2026 | 278 | 12,368 (0%) | 0% | 24.3 | 6,753 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 01 Jul 2026 | 278 | 12,368 (0%) | 0% | 24.3 | 6,753 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 01 Jul 2026 | 278 | 12,368 (0%) | 0% | 24.3 | 6,753 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.66 per share. | 15 Jun 2026 | 1,357 | 42,067 (0%) | 0% | 20.7 | 28,036 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.66 per share. | 15 Jun 2026 | 1,153 | 35,755 (0%) | 0% | 20.7 | 23,821 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 15 Jun 2026 | 550 | 22,029 (0%) | 0% | 2.4 | 1,315 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 550 | 91,881 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.66 per share. | 15 Jun 2026 | 550 | 21,479 (0%) | 0% | 20.7 | 11,363 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.66 per share. | 15 Jun 2026 | 278 | 12,646 (0%) | 0% | 20.7 | 5,743 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.66 per share. | 15 Jun 2026 | 278 | 12,646 (0%) | 0% | 20.7 | 5,743 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.66 per share. | 15 Jun 2026 | 278 | 12,646 (0%) | 0% | 20.7 | 5,743 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.66 per share. | 15 Jun 2026 | 278 | 12,646 (0%) | 0% | 20.7 | 5,743 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 01 Jun 2026 | 6,214 | 21,479 (0%) | 0% | 20.9 | 129,605 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 6,010 | 92,431 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 01 Jun 2026 | 6,010 | 27,693 (0%) | 0% | 2.4 | 14,364 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 01 Jun 2026 | 1,357 | 43,424 (0%) | 0% | 20.9 | 28,303 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 01 Jun 2026 | 1,153 | 36,908 (0%) | 0% | 20.9 | 24,048 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 01 Jun 2026 | 278 | 1,668 (0%) | 0% | 20.9 | 5,798 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 01 Jun 2026 | 278 | 1,668 (0%) | 0% | 20.9 | 5,798 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 01 Jun 2026 | 278 | 1,668 (0%) | 0% | 20.9 | 5,798 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 01 Jun 2026 | 278 | 1,668 (0%) | 0% | 20.9 | 5,798 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 01 Jun 2026 | 204 | 21,683 (0%) | 0% | 2.4 | 488 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 204 | 0 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 20 May 2026 | 1,035 | 44,781 (0%) | 0% | 20.2 | 20,903 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 20 May 2026 | 880 | 38,061 (0%) | 0% | 20.2 | 17,772 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 20 May 2026 | 420 | 21,479 (0%) | 0% | 20.2 | 8,482 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2026 | 420 | 204 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 20 May 2026 | 420 | 21,899 (0%) | 0% | 2.4 | 1,004 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 20 May 2026 | 322 | 45,816 (0%) | 0% | 20.0 | 6,441 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 20 May 2026 | 273 | 38,941 (0%) | 0% | 20.0 | 5,461 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 20 May 2026 | 212 | 1,946 (0%) | 0% | 20.2 | 4,282 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 20 May 2026 | 212 | 1,946 (0%) | 0% | 20.2 | 4,282 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 20 May 2026 | 212 | 1,946 (0%) | 0% | 20.2 | 4,282 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 20 May 2026 | 212 | 1,946 (0%) | 0% | 20.2 | 4,282 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 20 May 2026 | 130 | 21,609 (0%) | 0% | 2.4 | 311 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2026 | 130 | 624 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 20 May 2026 | 130 | 21,479 (0%) | 0% | 20 | 2,600 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 20 May 2026 | 66 | 2,158 (0%) | 0% | 20 | 1,320 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 20 May 2026 | 66 | 2,158 (0%) | 0% | 20 | 1,320 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 20 May 2026 | 66 | 2,158 (0%) | 0% | 20 | 1,320 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 20 May 2026 | 66 | 2,158 (0%) | 0% | 20 | 1,320 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 07 May 2026 | 6,214 | 27,693 (0%) | 0% | 2.4 | 14,851 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2026 | 6,214 | 754 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.08 per share. | 07 May 2026 | 5,308 | 22,385 (0%) | 0% | 22.1 | 117,201 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.08 per share. | 07 May 2026 | 1,159 | 46,336 (0%) | 0% | 22.1 | 25,591 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.08 per share. | 07 May 2026 | 985 | 39,382 (0%) | 0% | 22.1 | 21,749 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.58 per share. | 07 May 2026 | 906 | 21,479 (0%) | 0% | 22.6 | 20,462 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.08 per share. | 07 May 2026 | 237 | 2,265 (0%) | 0% | 22.1 | 5,233 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.08 per share. | 07 May 2026 | 237 | 2,265 (0%) | 0% | 22.1 | 5,233 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.08 per share. | 07 May 2026 | 237 | 2,265 (0%) | 0% | 22.1 | 5,233 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.08 per share. | 07 May 2026 | 237 | 2,265 (0%) | 0% | 22.1 | 5,233 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.59 per share. | 07 May 2026 | 198 | 46,138 (0%) | 0% | 22.6 | 4,472 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.58 per share. | 07 May 2026 | 168 | 39,214 (0%) | 0% | 22.6 | 3,794 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.59 per share. | 07 May 2026 | 41 | 2,224 (0%) | 0% | 22.6 | 926 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.59 per share. | 07 May 2026 | 41 | 2,224 (0%) | 0% | 22.6 | 926 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.59 per share. | 07 May 2026 | 41 | 2,224 (0%) | 0% | 22.6 | 926 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 22.59 per share. | 07 May 2026 | 41 | 2,224 (0%) | 0% | 22.6 | 926 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.10 per share. | 21 Apr 2026 | 1,357 | 47,495 (0%) | 0% | 25.1 | 34,058 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.10 per share. | 21 Apr 2026 | 1,153 | 40,367 (0%) | 0% | 25.1 | 28,938 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2026 | 550 | 6,968 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 21 Apr 2026 | 550 | 22,029 (0%) | 0% | 2.4 | 1,315 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.10 per share. | 21 Apr 2026 | 550 | 21,479 (0%) | 0% | 25.1 | 13,804 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.10 per share. | 21 Apr 2026 | 278 | 2,502 (0%) | 0% | 25.1 | 6,977 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.10 per share. | 21 Apr 2026 | 278 | 2,502 (0%) | 0% | 25.1 | 6,977 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.10 per share. | 21 Apr 2026 | 278 | 2,502 (0%) | 0% | 25.1 | 6,977 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.10 per share. | 21 Apr 2026 | 278 | 2,502 (0%) | 0% | 25.1 | 6,977 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 06 Apr 2026 | 6,214 | 27,693 (0%) | 0% | 2.4 | 14,851 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2026 | 6,214 | 7,518 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 06 Apr 2026 | 6,214 | 21,479 (0%) | 0% | 25.0 | 155,536 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 06 Apr 2026 | 1,357 | 48,852 (0%) | 0% | 25.0 | 33,966 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 06 Apr 2026 | 1,153 | 41,520 (0%) | 0% | 25.0 | 28,860 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 06 Apr 2026 | 278 | 2,780 (0%) | 0% | 25.0 | 6,958 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 06 Apr 2026 | 278 | 2,780 (0%) | 0% | 25.0 | 6,958 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 06 Apr 2026 | 278 | 2,780 (0%) | 0% | 25.0 | 6,958 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 06 Apr 2026 | 278 | 2,780 (0%) | 0% | 25.0 | 6,958 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.55 per share. | 26 Mar 2026 | 1,357 | 50,209 (0%) | 0% | 25.6 | 34,673 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.55 per share. | 26 Mar 2026 | 1,153 | 42,673 (0%) | 0% | 25.6 | 29,460 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.55 per share. | 26 Mar 2026 | 550 | 21,479 (0%) | 0% | 25.6 | 14,053 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 26 Mar 2026 | 550 | 22,029 (0%) | 0% | 2.4 | 1,315 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2026 | 550 | 13,732 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.55 per share. | 26 Mar 2026 | 278 | 3,058 (0%) | 0% | 25.6 | 7,103 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.55 per share. | 26 Mar 2026 | 278 | 3,058 (0%) | 0% | 25.6 | 7,103 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.55 per share. | 26 Mar 2026 | 278 | 3,058 (0%) | 0% | 25.6 | 7,103 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.55 per share. | 26 Mar 2026 | 278 | 3,058 (0%) | 0% | 25.6 | 7,103 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.93 per share. | 17 Mar 2026 | 18,650 | 22,129 (0%) | 0% | 25.9 | 483,595 | Common Stock |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 25.39 per share. | 17 Mar 2026 | 650 | 21,479 (0%) | 0% | 25.4 | 16,504 | Common Stock |